Xilliga Shark Tank India 2, fikrado ganacsi oo badan oo gaar ah ayaa awood u leh inay kor u qaadaan maalgashiga, iyagoo ku nool rajooyinka Sharks. CureSee Vision Therapy on Shark Tank India waa kacaan kale AI -Fikrad ku salaysan oo soo jiitay garsoorayaasha oo ka dhigay inay u dagaalamaan heshiis.
Bandhiga TV-ga dhabta ah ee Shark Tank India wuxuu siinayaa fursad ay ku ganacsadaan dhammaan dalka oo dhan si ay fikradahooda ganacsi u soo bandhigaan guddi maalgashadayaal suurtagal ah. Kooxda sharks-ka ayaa markaa lacagtooda gelisa fikradda si ay ugu beddelaan saamiga lahaanshaha ee shirkadda.
Xilligii 1-aad ee ka dambeeyay, bandhiggu waxa uu soo jiitay mowjado ganacsi oo maal-gelin doona, iyo qaybtii u dambaysay, shirkad lagu magacaabo CureSee ayaa soo bandhigtay fikradooda. Maamulaha guud ee Lenskart Piyush Bansal ayaa heshiis la galay ka dib markii uu soo jiitay garsoorayaasha. Waa kuwan wax walba oo ka dhacay bandhigga.
Table of Contents
CureSee Aragtida Therapy ee Haamaha Shark India
Gudaha Shark Tank India Season 2 Episode 34, CureSee Vision Therapy wakiilada waxay dareensiiyeen joogitaankooda iyagoo soo bandhigaya garaadkooda 1st ee Artificial Intelligence (AI) ee ku salaysan Vision Therapy Software ee Amblyopia ama isha caajiska ah. Waxay ka dhigtay Namita Thapar Agaasimaha Emcure Pharmaceuticals iyo Piyush Bansal aasaasaha iyo maamulaha Lenskart ee caanka ah inay u dagaalamaan helitaanka heshiiska.
Labaduba waxay rabeen inay maalgashadaan ka dib markay maqleen garoonka waxayna bilaabeen inay sharaxaan aragtidooda shirkadda daaweynta aragga ee AI ku salaysan. Marka sidaas la samaynayo, Bansal wuxuu diiday mid kasta oo ka mid ah aragtiyaha Thapar ee jaladaha, taasoo horseedaysa in labadooduba ay isweyddiiyaan midba midka kale.
Bansal waxa uu sheegay in aanu rumaysnayn qaabka uu Thapar u doortay shirkadda. Waxa uu ku andacoonayaa in aanu si toos ah ugu soo dhawaanin sidii uu madasha uga bartay, sidaa awgeedna aanu waligiis u soo dhawaan. Thapar waxa uu waydiiyay sababta uu waligiis ugu soo dhowaanin markii uu ka bartay madasha.
Arrimuhu way sii bateen markii ay labadooduba galeen dagaal tartan. Namita ayaa markii hore bixisay Rs 40 lakh 7.5 boqolkiiba sinnaanta, halka Piyush uu bixiyay Rs 40 lakh 10 boqolkiiba sinnaanta. Ka dib xoogaa ereyo adag ah iyo dagaal tartan, wakiilada CureSee waxay doorteen soo jeedinta dib loo eegay ee Piyush ee 50 lakhs ee 10% sinnaanta.
CureSee Aragtida Daaweynta Taangiga Shark India - Qodobbada ugu waaweyn
| Magaca bilowga | CureSee Daaweynta Aragga |
| Hawlgalka Bilawga | Sii daawayn shakhsi ahaaneed oo la qabsi ah bukaanada qaba amblyopia isticmaalaya AI |
| Magaca aasaasaha CureSee | Puneet, Jatin Kaushik, Amit Sahn |
| Ku daridda CureSee | 2019 |
| Cure Eeg Weydii Hore | 40 lakhs 5% sinnaanta |
| Qiimaha Shirkadda | 5 crore |
| CureSee Deal ee Haanta Shark | 50 lakhs 10% sinnaanta |
| Maal | Piyush Bansal |
Waa maxay CureSee Vision Therapy
Aasaasayaashu waxay sheeganayaan in CureSee uu yahay sirdoonka ugu horreeya ee Artificial Intelligence (AI) software daweynta aragga ku salaysan ee adduunka daawaynta Amblyopia. Layli kala duwan ayaa la bixiyaa si kor loogu qaado aragga iyo sidoo kale tiro barnaamijyo ah oo ka caawinaya la dagaallanka arrimaha indhaha sida amblyopia.
Qof kastaa wuu ka faa'iidaysan karaa barnaamijkan jimicsiga indhaha ee awood siiya korna u qaadaya aragiisa. Qof kastaa wuu isticmaali karaa, iyadoon loo eegayn da'diisa ama awoodiisa muuqaal. Way fududahay in la isticmaalo lagana heli karo meel kasta. Maadaama uu barnaamijku ka hortagayo oo uu yareynayo khatarta dhibaatooyinka aragga, waa doorasho ku habboon dadka doonaya in ay ilaaliyaan caafimaadka indhaha ee wanaagsan.
Jimicsiyada Amblyopia waa barnaamij gaar ah oo loo sameeyay bukaanada qaba amblyopia, oo inta badan loo yaqaan "indho caajis ah". Iyadoo la adeegsanayo tignoolajiyada sirdoonka macmalka ah ee jeexan, barnaamijku wuxuu bixiyaa jimicsi shaqsiyeed, laqabsi oo ku saleysan horumarka isticmaale kasta. Bukaanjiifka Amblyopia waxay dib u heli karaan aragooda aragooda waxayna hagaajin karaan aragooda barnaamijkan, kaas oo la caddeeyay inuu yahay daawaynta ugu waxtarka badan.
Shirkaddu waxay leedahay saddex aasaase iyo saddex sarkaal oo hawl-wadeenno ah: Puneet, Jatin Kaushik, iyo Amit Sahni. Iyada oo ku saleysan macluumaadka ay bixiyeen aasaasayaashu, waxay daweysay ku dhawaad 2500 bukaan tan iyo 2019. Hadda, shirkaddu waxay leedahay in ka badan 200 dhakhaatiir waxayna ka shaqeysaa in ka badan 40 goobood.
Waxa kale oo laga yaabaa inaad rabto inaad hubiso CloudWorx On Shark Tank India
Ugu Dambeyn
CureSee Vision Therapy On Shark Tank India waxay awooday inay soo jiidato dhammaan garsoorayaasha oo ay heshiis la gasho shark xidhiidh la leh ganacsigooda oo si weyn u caawin kara. Sida laga soo xigtay sharks on show, waa bilow bilow ah oo caawin doona dad badan oo la ildaran dhibaatooyinka aragga.